Rigel Pharmaceuticals (RIGL) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.56% |
| Dec 31, 2025 | 23.55% |
| Sep 30, 2025 | -42.53% |
| Jun 30, 2025 | -120.58% |
| Mar 31, 2025 | 3.32% |
| Dec 31, 2024 | -387.06% |
| Sep 30, 2024 | -65.21% |
| Jun 30, 2024 | 3,391.69% |
| Mar 31, 2024 | 104.55% |
| Dec 31, 2023 | -487.52% |
| Sep 30, 2023 | -139.39% |
| Jun 30, 2023 | 282.24% |
| Mar 31, 2023 | -95.82% |
| Dec 31, 2022 | 77.89% |
| Sep 30, 2022 | -50.44% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | 248.78% |
| Dec 31, 2021 | 114.61% |
| Sep 30, 2021 | 10.60% |
| Jun 30, 2021 | -759.31% |
| Mar 31, 2021 | -13.53% |
| Dec 31, 2020 | -55.39% |
| Sep 30, 2020 | 473.10% |
| Jun 30, 2020 | -121.40% |
| Mar 31, 2020 | 421.14% |
| Dec 31, 2019 | -2,490.82% |
| Sep 30, 2019 | 98.00% |
| Jun 30, 2019 | -1,267.38% |
| Mar 31, 2019 | -151.27% |
| Dec 31, 2018 | -86.80% |
| Sep 30, 2018 | 197.86% |
| Jun 30, 2018 | -169.78% |
| Mar 31, 2018 | 165.89% |
| Dec 31, 2017 | -566.08% |
| Sep 30, 2017 | -9.51% |
| Jun 30, 2017 | 5,670.67% |
| Mar 31, 2017 | -107.11% |
| Dec 31, 2016 | -79.69% |
| Sep 30, 2016 | -45.72% |
| Jun 30, 2016 | 382.79% |
| Mar 31, 2016 | -153.11% |
| Dec 31, 2015 | -58.40% |
| Sep 30, 2015 | 469.50% |
| Jun 30, 2015 | -187.20% |
| Mar 31, 2015 | -43.77% |
| Dec 31, 2014 | 131.56% |
| Sep 30, 2014 | -74.15% |
| Jun 30, 2014 | 170.12% |
| Mar 31, 2014 | -55.48% |
| Dec 31, 2013 | 57.63% |
| Sep 30, 2013 | 81.60% |
| Jun 30, 2013 | -68.17% |
| Mar 31, 2013 | 123.82% |
| Dec 31, 2012 | -667.49% |
| Sep 30, 2012 | -20.41% |
| Jun 30, 2012 | -8.45% |
| Mar 31, 2012 | 46.81% |
| Dec 31, 2011 | 255.12% |
| Sep 30, 2011 | 89.25% |
| Jun 30, 2011 | -383.08% |
| Mar 31, 2011 | 257.76% |
| Dec 31, 2010 | -370.04% |